- Home
- BRKR vs BCPC Comparison
BRKR vs BCPC Comparison
Compare BRKR & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRKR
- BCPC
- Stock Information
- Founded
- BRKR 1960
- BCPC 1967
- Country
- BRKR United States
- BCPC United States
- Employees
- BRKR N/A
- BCPC N/A
- Industry
- BRKR Biotechnology: Laboratory Analytical Instruments
- BCPC Major Chemicals
- Sector
- BRKR Industrials
- BCPC Industrials
- Exchange
- BRKR Nasdaq
- BCPC Nasdaq
- Market Cap
- BRKR 6.4B
- BCPC 5.2B
- IPO Year
- BRKR 2000
- BCPC N/A
- Fundamental
- Price
- BRKR $38.43
- BCPC $152.47
- Analyst Decision
- BRKR Buy
- BCPC Strong Buy
- Analyst Count
- BRKR 12
- BCPC 1
- Target Price
- BRKR $54.50
- BCPC $180.00
- AVG Volume (30 Days)
- BRKR 3.3M
- BCPC 171.9K
- Earning Date
- BRKR 08-04-2025
- BCPC 07-31-2025
- Dividend Yield
- BRKR 0.52%
- BCPC 0.57%
- EPS Growth
- BRKR N/A
- BCPC 21.42
- EPS
- BRKR 0.52
- BCPC 4.36
- Revenue
- BRKR $3,446,100,000.00
- BCPC $985,930,000.00
- Revenue This Year
- BRKR $6.52
- BCPC $8.74
- Revenue Next Year
- BRKR $3.88
- BCPC $6.85
- P/E Ratio
- BRKR $73.17
- BCPC $35.04
- Revenue Growth
- BRKR 14.84
- BCPC 5.74
- 52 Week Low
- BRKR $34.10
- BCPC $145.70
- 52 Week High
- BRKR $72.94
- BCPC $185.96
- Technical
- Relative Strength Index (RSI)
- BRKR 43.54
- BCPC 39.70
- Support Level
- BRKR $34.62
- BCPC $146.41
- Resistance Level
- BRKR $44.36
- BCPC $153.86
- Average True Range (ATR)
- BRKR 2.05
- BCPC 3.63
- MACD
- BRKR -0.21
- BCPC -0.15
- Stochastic Oscillator
- BRKR 39.12
- BCPC 41.39
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
About BCPC Balchem Corporation
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.